Republican Leaders In Congress Want To Undercut Drug Pricing Law: What’s The Opportunity?

US Mid-Term Elections And The Inflation Reduction Act

As Republicans expand their power in Congress, experts weigh in on prospects for significant changes to the Medicare price negotiation law and what the GOP might do to hamper implementation of the program.

Biden midterms
Can President Biden and Republican leaders in Congress find common ground on drug pricing? • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock, Getty images

With Republicans projected to take control of the US House and perhaps the Senate following the mid-term elections, the biopharma industry has an opportunity to marshal Congressional sympathies to weaken the Medicare drug price negotiation program established by President Biden’s Inflation Reduction Act.

As of press time Tuesday, the GOP seemed on track to win a majority of House seats, with the Senate...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Elections

More from Legislation